Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 23 (32), 5954-5961

Modified Helicobacter Test Using a New Test Meal and a 13 C-urea Breath Test in Helicobacter pylori Positive and Negative Dyspepsia Patients on Proton Pump Inhibitors

Affiliations
Randomized Controlled Trial

Modified Helicobacter Test Using a New Test Meal and a 13 C-urea Breath Test in Helicobacter pylori Positive and Negative Dyspepsia Patients on Proton Pump Inhibitors

Bojan Tepeš et al. World J Gastroenterol.

Abstract

Aim: To determine the sensitivity and specificity of the 13C-urea breath test (UBT) in patients taking proton pump inhibitors (PPIs), using a new test meal Refex.

Methods: One hundred and fourteen consecutive patients with dyspepsia, 53 Helicobacter pylori (H. pylori) positive, 49 H. pylori negative, were included in the study. The patients were then given esomeprazole 40 mg for 29 consecutive days, and the 13C-UBT with the new test meal was performed the next morning.

Results: The sensitivity of the 13C-UBT with a cut off 2.5‰ was 92.45% (95%CI: 81.79%-97.91%) by per-protocol (PP) analysis and 78.13% (95%CI: 66.03%-87.49%) by intention-to-treat (ITT) analysis. The specificity of the 13C-UBT test was 96.00% in the ITT population (95%CI: 86.29%-99.51%) and 97.96% in the PP population (95%CI: 89.15%-99.95%).

Conclusion: The new test meal based 13C-UBT is highly accurate in patients on PPIs and can be used in those unable to stop their PPI treatment.

Keywords: Helicobacter pylori; New test meal; Prospective randomized clinical trial; Proton pump inhibitors; Urea breath test.

Conflict of interest statement

Conflict-of-interest statement: The authors of this manuscript having no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram. The patient population and results of Helicobacter pylori diagnosis (based on study criteria and UBT with standard test meal and new test meal after 29 d of PPI treatment). UBT: Urea breath test; ITT: Intention-to-treat; PPI: Proton pump inhibitors; Hp: Helicobacter pylori.
Figure 2
Figure 2
Empirical receiver operating characteristic curve by using cut-off values of 2.0‰, 2.5‰ and 3.0‰ (Per-protocol population, n = 102).

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

References

    1. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30. - PubMed
    1. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61:646–664. - PubMed
    1. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 1998;114:579–581. - PubMed
    1. Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, Miglioli M, Vaira D. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004;99:823–829. - PubMed
    1. Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, Niv Y, Avni Y, Shirin H. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole. Aliment Pharmacol Ther. 2004;20:117–122. - PubMed

Publication types

MeSH terms

Feedback